Vicapsys Life Sciences annual current ratio
2019
2020
2021
2022
2023
Vicapsys Life Sciences Current Ratio Growth & History (VICP)
Vicapsys Life Sciences's current ratio was 0.02 for fiscal 2023.
View full Vicapsys Life Sciences company overviewVicapsys Life Sciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | 0.02 | −0.05 | −71.39% |
| 2022 | 2022-12-31 | 0.07 | −0.24 | −77.37% |
| 2021 | 2021-12-31 | 0.31 | 0.31 | +20822.41% |
| 2020 | 2020-12-31 | 0.00 | −0.66 | −99.78% |
| 2019 | 2019-12-31 | 0.67 | — | — |
Vicapsys Life Sciences quarterly current ratio
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q3.24
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | 0.03 | −0.10 | −75.78% |
| Q4 2023 | 2023-12-31 | 0.02 | −0.05 | −71.39% |
| Q3 2023 | 2023-09-30 | 0.14 | 0.10 | +241.86% |
| Q2 2023 | 2023-06-30 | 0.26 | 0.23 | +728.35% |
| Q1 2023 | 2023-03-31 | 0.05 | −0.10 | −64.86% |
| Q4 2022 | 2022-12-31 | 0.07 | −0.24 | −77.37% |
| Q3 2022 | 2022-09-30 | 0.04 | −0.18 | −82.18% |
| Q2 2022 | 2022-06-30 | 0.03 | −0.18 | −85.46% |
| Q1 2022 | 2022-03-31 | 0.15 | 0.11 | +270.08% |
| Q4 2021 | 2021-12-31 | 0.31 | 0.31 | +20822.41% |
| Q3 2021 | 2021-09-30 | 0.22 | 0.22 | +4737.41% |
| Q2 2021 | 2021-06-30 | 0.21 | 0.20 | +1609.72% |
| Q1 2021 | 2021-03-31 | 0.04 | −0.02 | −32.36% |
| Q4 2020 | 2020-12-31 | 0.00 | −0.66 | −99.78% |
| Q3 2020 | 2020-09-30 | 0.00 | — | — |
| Q2 2020 | 2020-06-30 | 0.01 | — | — |
| Q1 2020 | 2020-03-31 | 0.06 | — | — |
| Q4 2019 | 2019-12-31 | 0.67 | — | — |
Vicapsys Life Sciences current ratio trends
Between the periods ended 2019-12-31 and 2023-12-31, Vicapsys Life Sciences's current ratio decreased from 0.67 to 0.02, a change of −0.65. The latest reported quarter, Q3 2024, shows 0.03.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vicapsys Life Sciences source filings ↗